MAPT and hereditary spastic paraplegia: BD-tau could theoretically offer an advantage over conventional plasma t-tau in capturing CNS-specific neurodegeneration in complex HSP phenotypes or in detecting disease conversion, but this requires validation, and multicenter longitudinal studies.